期刊文献+

824例肝硬化病因及相关分析 被引量:21

Etiological analysis of liver cirrhosis of 824 cases
下载PDF
导出
摘要 目的探讨近年来我国肝硬化病因的特点及其变化。方法回顾性分析我院1994年1月~2004年12月824例肝硬化出院患者的病因。结果乙型肝炎后肝硬化504例(61.17%),酒精性肝硬化73例(8.86%),乙型病毒性肝炎合并酒精性肝硬化152例(18.45%),自身免疫性肝硬化19例(2.31%),非酒精性脂肪性肝硬化者31例(3.76%)。按时期分为前6年和后5年分别分析。显示乙型肝炎肝硬化由66.67%下降到57.65%,随时间呈下降趋势。酒精性肝硬化由2.49%增加到12.92%,非酒精性脂肪性肝硬化由1.56%增加到5.19%,自身免疫性肝硬化由1.25%增加到2.98%,均随时间呈增加趋势。本组患者中139例(16.87%)合并原发性肝癌,其中128例为乙肝后肝硬化,9例酒精性肝硬化,1例非酒精性脂肪性肝硬化。结论虽然乙型病毒性肝炎仍然为我国肝硬化的主要病因,但是酒精性肝硬化和非酒精性脂肪性肝硬化随时间呈上升趋势,且非酒精性脂肪性肝硬化的预后与乙肝后肝硬化比较差异无统计学意义,应该引起足够重视。 Objective To analyze the causes of liver cirrhosis and their changes in recent years in the Second Affiliated Clinical College of Chongqing University of Medical Sciences. Methods Eight hundreds and twenty-four inpatients with liver cirrhosis(Jan. 1994 to Dec. 2004)were investigated retrospectively. Results Five hundreds four(61.17% )cases were caused by the infection of hepatitis B virus. Thirty(3.76 % )cases were caused by NAFLD and 73(8.86 % )cases were caused by alcohol . Two factors(hepatitis B virus and alcohol)existed in 152(18.45 %0 ) patients . The patients were divided into two groups of before-Jan. 2000 and after- Jan. 2000,and the above etiological factors were further analyzed . It was found that the incidence of alcoholic cirrhosis increased from 2.49% to 12.92% ,also the incidence of cirrhosis caused by NAFLD increased from 1.56% to 5.19% . But the incidence of cirrhosis caused by HBV was decreased from 66.67 % to 57.65 % . Conclusion It is suggested that HBV is still the major cause of liver cirrhosis in China. Cirrhosis caused by alcohol and NAFLD reveals a tendency of increase, to which much attention should be paid.
作者 张鸣 沈薇
出处 《重庆医学》 CAS CSCD 2006年第5期438-439,441,共3页 Chongqing medicine
关键词 肝硬化 病因 病毒性肝炎 酒精 非酒精性脂肪性肝病 cirrhosis etiology, viral hepat itis alcohol NAFLD(nonalcoholic fatty liver disease)
  • 相关文献

参考文献5

二级参考文献7

  • 1Kelley DE, McKolanis TM, Hegazi RA, et al. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab, 2003, 285: E906-E916.
  • 2Meigs JB, Wilson PW, Nathan DM, et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes, 2003, 52: 2160-2167.
  • 3Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab, 2000, 26: 98-106.
  • 4Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med, 1999, 107: 450-455.
  • 5Angulo P. Nonalcoholic fatty liver disease. N Engl J Med, 2002, 346: 1221-1231.
  • 6中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊断标准[J].中华肝脏病杂志,2003,11(2):71-71. 被引量:1365
  • 7史轶蘩,朱惠娟.降低体重在非酒精性脂肪性肝病防治中的作用[J].中华肝脏病杂志,2003,11(2):112-112. 被引量:20

共引文献1394

同被引文献185

引证文献21

二级引证文献159

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部